Business Description
Trilogy AI Corp
NAICS : 446199
SIC : 6599
ISIN : CA02316X1024
Description
Trilogy AI Corp formerly Ambari Brands Incy is an emerging cosmetic company. It is a luxury skincare and consumer packaged goods company and has developed a product line on its proprietary Modern Blend. It generates revenue from the sale of skincare products directly to consumers and luxury department stores, and on a wholesale basis to distributors and spas.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.43 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -77.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.24 | |||||
| 9-Day RSI | 38.48 | |||||
| 14-Day RSI | 41.21 | |||||
| 6-1 Month Momentum % | -30.74 | |||||
| 12-1 Month Momentum % | -73.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.74 | |||||
| Quick Ratio | 1.74 | |||||
| Cash Ratio | 1.27 | |||||
| Days Inventory | 33069 | |||||
| Days Payable | 5055.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -37.91 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 105.62 | |||||
| Operating Margin % | 1886.52 | |||||
| Net Margin % | 2847.19 | |||||
| FCF Margin % | 2150 | |||||
| ROE % | -430.04 | |||||
| ROA % | -347.12 | |||||
| ROIC % | -237.65 | |||||
| ROC (Joel Greenblatt) % | -276.83 | |||||
| ROCE % | -285.06 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 70 | |||||
| EV-to-EBIT | -2.34 | |||||
| EV-to-EBITDA | -2.34 | |||||
| EV-to-Revenue | -44.11 | |||||
| EV-to-FCF | -2.04 | |||||
| Earnings Yield (Greenblatt) % | -42.74 | |||||
| FCF Yield % | -48.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TRAIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Trilogy AI Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | -0.066 | ||
| EPS (TTM) ($) | -0.028 | ||
| Beta | 0 | ||
| Volatility % | 73.36 | ||
| 14-Day RSI | 41.21 | ||
| 14-Day ATR ($) | 0.015496 | ||
| 20-Day SMA ($) | 0.058267 | ||
| 12-1 Month Momentum % | -73.93 | ||
| 52-Week Range ($) | 0.0164 - 0.23218 | ||
| Shares Outstanding (Mil) | 56.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Trilogy AI Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Trilogy AI Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Trilogy AI Corp Frequently Asked Questions
What is Trilogy AI Corp(TRAIF)'s stock price today?
The current price of TRAIF is $0.04. The 52 week high of TRAIF is $0.23 and 52 week low is $0.02.
When is next earnings date of Trilogy AI Corp(TRAIF)?
The next earnings date of Trilogy AI Corp(TRAIF) is .
Does Trilogy AI Corp(TRAIF) pay dividends? If so, how much?
Trilogy AI Corp(TRAIF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers